Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges

Nika Mohannak,1 Gemma Pattison,2 Kathryn Hird,1 Merrilee Needham1,3,4 1School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia; 2Department of Speech Pathology, Royal Perth Hospital, Perth, Western Australia, Australia; 3Department of Neurology, Fiona Stanley Hospit...

Full description

Bibliographic Details
Main Authors: Mohannak N, Pattison G, Hird K, Needham M
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/dysphagia-in-patients-with-sporadic-inclusion-body-myositis-management-peer-reviewed-article-IJGM
_version_ 1819262773828255744
author Mohannak N
Pattison G
Hird K
Needham M
author_facet Mohannak N
Pattison G
Hird K
Needham M
author_sort Mohannak N
collection DOAJ
description Nika Mohannak,1 Gemma Pattison,2 Kathryn Hird,1 Merrilee Needham1,3,4 1School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia; 2Department of Speech Pathology, Royal Perth Hospital, Perth, Western Australia, Australia; 3Department of Neurology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia; 4Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, AustraliaCorrespondence: Merrilee NeedhamInstitute for Immunology and Infectious Diseases, Murdoch University, Building 390 Discovery Way, Murdoch, WA 6150, AustraliaTel +61 8 9360 1334Fax +61 8 9360 1380Email Merrilee.Needham@health.wa.gov.auAbstract: Dysphagia in inclusion body myositis (IBM) is common and associated with increased mortality and morbidity due to aspiration pneumonia, malnutrition and dehydration. There is currently no consensus on treatment of dysphagia in IBM and outcomes are variable depending on timing of intervention, patient preference and available expertise. There is a paucity of research exploring the pathophysiology of dysphagia in IBM and appropriate investigations. Increased knowledge of the aetiopathogenesis is likely to change the approach to treatment as well as improve the quality of life for patients. This review explores the epidemiology and pathophysiology of dysphagia in IBM and the currently available treatment strategies.Keywords: inflammatory myopathies, swallowing, epidemiology, pathophysiology, treatment, diagnosis
first_indexed 2024-12-23T20:03:02Z
format Article
id doaj.art-396434b5bb764c77a60b6db74af62eef
institution Directory Open Access Journal
issn 1178-7074
language English
last_indexed 2024-12-23T20:03:02Z
publishDate 2019-12-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj.art-396434b5bb764c77a60b6db74af62eef2022-12-21T17:33:01ZengDove Medical PressInternational Journal of General Medicine1178-70742019-12-01Volume 1246547450230Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management ChallengesMohannak NPattison GHird KNeedham MNika Mohannak,1 Gemma Pattison,2 Kathryn Hird,1 Merrilee Needham1,3,4 1School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia; 2Department of Speech Pathology, Royal Perth Hospital, Perth, Western Australia, Australia; 3Department of Neurology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia; 4Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, AustraliaCorrespondence: Merrilee NeedhamInstitute for Immunology and Infectious Diseases, Murdoch University, Building 390 Discovery Way, Murdoch, WA 6150, AustraliaTel +61 8 9360 1334Fax +61 8 9360 1380Email Merrilee.Needham@health.wa.gov.auAbstract: Dysphagia in inclusion body myositis (IBM) is common and associated with increased mortality and morbidity due to aspiration pneumonia, malnutrition and dehydration. There is currently no consensus on treatment of dysphagia in IBM and outcomes are variable depending on timing of intervention, patient preference and available expertise. There is a paucity of research exploring the pathophysiology of dysphagia in IBM and appropriate investigations. Increased knowledge of the aetiopathogenesis is likely to change the approach to treatment as well as improve the quality of life for patients. This review explores the epidemiology and pathophysiology of dysphagia in IBM and the currently available treatment strategies.Keywords: inflammatory myopathies, swallowing, epidemiology, pathophysiology, treatment, diagnosishttps://www.dovepress.com/dysphagia-in-patients-with-sporadic-inclusion-body-myositis-management-peer-reviewed-article-IJGMinflammatory myopathiesswallowingepidemiologypathophysiologytreatmentdiagnosis
spellingShingle Mohannak N
Pattison G
Hird K
Needham M
Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
International Journal of General Medicine
inflammatory myopathies
swallowing
epidemiology
pathophysiology
treatment
diagnosis
title Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
title_full Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
title_fullStr Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
title_full_unstemmed Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
title_short Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
title_sort dysphagia in patients with sporadic inclusion body myositis management challenges
topic inflammatory myopathies
swallowing
epidemiology
pathophysiology
treatment
diagnosis
url https://www.dovepress.com/dysphagia-in-patients-with-sporadic-inclusion-body-myositis-management-peer-reviewed-article-IJGM
work_keys_str_mv AT mohannakn dysphagiainpatientswithsporadicinclusionbodymyositismanagementchallenges
AT pattisong dysphagiainpatientswithsporadicinclusionbodymyositismanagementchallenges
AT hirdk dysphagiainpatientswithsporadicinclusionbodymyositismanagementchallenges
AT needhamm dysphagiainpatientswithsporadicinclusionbodymyositismanagementchallenges